Title: Loan/loan guarantee outstanding balances
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of the Medical University of South Carolina (the University) and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards at Title 2 U.S. Code of Federal Regulation Part 200 (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic financial statements.
De Minimis Rate Used: N
Rate Explanation: The University did not elect to use the 10% de minimis indirect cost rate, as discussed in Uniform Guidance Section 200.414. (Note 5)
FEDERAL PERKINS LOAN PROGRAM (84.038) - Balances outstanding at the end of the audit period were 1507446. FEDERAL DIRECT STUDENT LOANS (84.268) - Balances outstanding at the end of the audit period were 101661081. NURSE FACULTY LOAN PROGRAM (NFLP) (93.264) - Balances outstanding at the end of the audit period were 1402771. NURSING STUDENT LOANS (93.364) - Balances outstanding at the end of the audit period were 2713515. HEALTH PROFESSIONS STUDENT LOANS, INCLUDING PRIMARY CARE LOANS/LOANS FOR DISADVANTAGED STUDENTS (93.342) - Balances outstanding at the end of the audit period were 5545142.
Title: (3) Noncash Assistance
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of the Medical University of South Carolina (the University) and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards at Title 2 U.S. Code of Federal Regulation Part 200 (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic financial statements.
De Minimis Rate Used: N
Rate Explanation: The University did not elect to use the 10% de minimis indirect cost rate, as discussed in Uniform Guidance Section 200.414. (Note 5)
Most federal financial assistance is in the form of cash awards. However, there are a number of federal programs that do not involve cash transactions with the University. These noncash transactions in which the University obtains other assistance are the Federal Direct Student Loan Program, which includes the Federal Direct Stafford Student Loan program (subsidized and unsubsidized) and the Federal Direct Parent Loans for Undergraduate Students (PLUS).The loans advanced and related expenditures are as follows for the various student loan programs:Federal Direct Student Loan Program Student loans advanced: ALN 84.268 Direct Stafford Loan Program $936,374 Direct Unsubsidized Stafford Loan Program 58,885,506 Federal Direct PLUS Loan Program 336,894 Federal Direct Graduate PLUS Loan Program 41,502,307 Total Federal Direct Student Loan Program $ 101,661,081 The Federal Perkins Loan, the Health Professions Student Loan (HPSL), the Nurse Faculty Loan Program (NFLP), and the Nursing Student Loan (NSL) programs are administered directly by the University, and balances and transactions relating to these programs are included in the Universitys basic financial statements. The balance of loans outstanding under the Federal Perkins, HPSL, NFLP, and NSL programs was $1,507,446, $5,545,142, $1,402,771, and $2,713,515, respectively, as of June 30, 2022. The University is responsible only for the performance of certain administrative duties with respect to the guaranteed student loan programs, and accordingly, these loans are not included in its financial statements. It is not practicable to determine the balance of loans outstanding to students and former students of the University under these programs as of June 30, 2022.
Title: (4) Matching
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of the Medical University of South Carolina (the University) and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards at Title 2 U.S. Code of Federal Regulation Part 200 (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic financial statements.
De Minimis Rate Used: N
Rate Explanation: The University did not elect to use the 10% de minimis indirect cost rate, as discussed in Uniform Guidance Section 200.414. (Note 5)
Under the FWS program, the University matched $43,079 in total compensation for the year endedJune 30, 2022 in addition to the federal share of expenditures in the accompanying schedule of expenditures of federal awards.Under the FSEOG program, the University matched $49,005 in funds awarded to students for the year ended June 30, 2022 in addition to the federal expenditures in the accompanying schedule of expenditures of federal awards.
Title: (6) Provider Relief Funding
Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of the Medical University of South Carolina (the University) and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards at Title 2 U.S. Code of Federal Regulation Part 200 (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic financial statements.
De Minimis Rate Used: N
Rate Explanation: The University did not elect to use the 10% de minimis indirect cost rate, as discussed in Uniform Guidance Section 200.414. (Note 5)
COVID-19 CARES Provider Relief (ALN 93.498) represents total expenditures and/or lost revenues from the Period 2 and 3 report submissions to the PRF Reporting Portal Period 2 is based on payments received from July 1, 2020 to December 31, 2020, with a period of availability of expenses and/or lost revenue from January 1, 2020 to December 31, 2021. Period 3 is based on payments received from January 1, 2021 to June 30, 2021, with a period of availability of expenses and/or lost revenue from January 1, 2020 toJune 30, 2022.